Cargando…
Late cART Initiation Consistently Driven by Late HIV Presentation: A Multicenter Retrospective Cohort Study in Taiwan from 2009 to 2019
INTRODUCTION: Late initiation (LI) of combination antiretroviral therapy (cART)—defined as having a CD4(+) count of < 200 cells/μL or an AIDS-defining disease at cART initiation—has detrimental outcomes but remains prevalent worldwide, with LI trends and etiologies following the implementation of...
Autores principales: | Lee, Chun-Yuan, Lin, Yi-Pei, Wang, Sheng-Fan, Lu, Po-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124249/ https://www.ncbi.nlm.nih.gov/pubmed/35301666 http://dx.doi.org/10.1007/s40121-022-00619-7 |
Ejemplares similares
-
Opportunistic infections and immune reconstitution inflammatory syndrome (IRIS) in HIV infected patient – late presenter in cART era: case report
por: Mitroi-Maxim, Corina, et al.
Publicado: (2014) -
Toxoplasmosis Encephalitis: A Cross-Sectional Analysis at a U.S.
Safety-Net Hospital in the Late cART Era
por: Lau, Abby, et al.
Publicado: (2021) -
Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV
por: Valcour, Victor G., et al.
Publicado: (2015) -
Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART
por: Musinguzi, Nicholas, et al.
Publicado: (2021) -
Effect of once-daily FDC treatment era on initiation of cART
por: Mosen, David M, et al.
Publicado: (2010)